October 13, 2016 TOULOUSE, France–(BUSINESS WIRE)– VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM / PEA‐PME), a medical device company specializing in the minimally invasive treatment of vertebral fractures, today announces its consolidated sales results for the third quarter 2016. « Vexim continues to develop according to its plan. Our results confirm the objectives set as the SpineJack® […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone